Displaying 21 - 30 of 86 for Cancer - All
  • CIVIC Study (H-39297)
    • The purpose of this study is to investigate the efficacy of autologous Epstein-Barr virus (EBV)-specific T cells for the treatment of EBV positive diffuse large B cell lymphoma, Hodgkin lymphoma, and post-transplant lymphoproliferative disease.
  • COXEN Study (H-35336)
    • The primary focus of this study is to see if looking at tumor biomarkers using a program called coexpression extrapolation or "COXEN" may predict a patient's response to chemotherapy before surgery.
  • CRIZENT Study (H-33624)
    • CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer - In this study the investigators will be combining both of these two treatments, but at different doses.
  • Dyskeratosis Congenita Study (H-40548)
    • The purpose of this study is to test whether a regimen that avoids DNA alkylators and radiation can permit successful BMT without compromising survival in patients with dyskeratosis congenita.
  • Esophageal Cancer Study (H-34973)
    • The purpose of this study is to determine whether the use of a low-cost, high-resolution microendoscope during diagnostic upper endoscopy can improve the efficiency and accuracy of endoscopic screening for esophageal squamous cell neoplasia.
  • GARNET: Advanced Solid Tumors (H-40511)
    • This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti programmed death receptor 1 (anti-PD-1) antibody TSR-042 in patients with advanced solid tumors who have limited available treatment options.
  • Glioblastoma (iCAR) Study (H-31973)
    • The purpose of this study is to find the largest safe dose of HER2-CAR T cells, to learn what the side effects are, and to see whether this experimental intervention might help patients with glioblastoma.
  • Glioblastoma Multiforme Study (H-37782)
    • This randomized phase II/III trial studies how well temozolomide and veliparib work compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.
  • GRALE Study (H-29617)
    • The purpose of this study is to find the largest safe dose of LMP-specific cytotoxic GRALE T cells created using this new manufacturing technique.
  • Head and Neck Cancer Biospecimen Collection Pilot Project (H-36565)
    • The purpose of this research is to discover genetic changes associated with cancer by documenting the changes that occur to the DNA, RNA and proteins found in head and neck cancer cells.